From Yahoo Finance: 2025-05-10 09:44:00

This week, the stock market saw a slight decline as investors prepared for crucial trade negotiations between the US and China. The Dow Jones dropped by 0.16%, the S&P 500 by 0.47%, and the Nasdaq by 0.27%. Despite this, 10 companies managed to outperform the market and experience significant gains.

Among these companies, Hims & Hers Health, Inc. (HIMS) stood out with a remarkable 27.29% increase in share prices. This surge was fueled by the company’s impressive earnings report, showing a 346% growth in net income and a 111% increase in revenues year-on-year. Investors also reacted positively to the announcement of strategic partnerships.

Hims & Hers Health, Inc. (HIMS) is confident in its future performance, updating its 2025 revenue guidance to $2.3 billion – $2.4 billion. The company recently secured a partnership with Novo Nordisk to market the weight loss drug Wegovy. Additional collaborations are in the pipeline, further enhancing HIMS’s growth prospects.

While HIMS ranks 9th among the top-performing stocks this week, the focus remains on AI stocks for potential higher returns in a shorter timeframe. Investors looking for promising AI investments can explore opportunities beyond HIMS, with specific recommendations provided in a recent report on the cheapest AI stock available.

Read more: Why Hims & Hers Health, Inc. (HIMS) Skyrocketed This Week